Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Obici

Showing results (61-70 of 204) with videos related to

Pageof 21
Sort By:
Annals of the Rheumatic Diseases|March 19, 2013
Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) geneCécile Rittore, Elodie Sanchez, Stephan Soler, et al.
European Journal of Dermatology : EJD|April 1, 2014
Hereditary apolipoprotein A1 amyloidosis with cutaneous and cardiac involvement: a long familial historyLuca Muscardin, Carlo Cota, Pietro Donati, et al.
Blood|September 16, 2011
Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissueFrancesca Brambilla, Francesca Lavatelli, Dario Di Silvestre, et al.
Journal of the Peripheral Nervous System : JPNS|June 23, 2011
Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patientsManuel Cappellari, Tiziana Cavallaro, Moreno Ferrarini, et al.
Journal of Cardiovascular Translational Research|October 9, 2013
Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosisGiampaolo Merlini, Violaine Planté-Bordeneuve, Daniel P Judge, et al.
Expert Review of Clinical Pharmacology|July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosisMorie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.
Haematologica|December 6, 2006
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosisVittorio Perfetti, Salvatore Siena, Giovanni Palladini, et al.
Annals of the Rheumatic Diseases|June 9, 2016
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II studyMarco Gattorno, Laura Obici, Marco Cattalini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2020
Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathyLuis F Maia, Aleksandra Maceski, Isabel Conceição, et al.
Arthritis and Rheumatism|October 1, 2004
First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndromeLaura Obici, Carlo Manno, Andrea Onetti Muda, et al.
Pageof 21

Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Annals of the Rheumatic Diseases|March 19, 2013
Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) geneCécile Rittore, Elodie Sanchez, Stephan Soler, et al.
European Journal of Dermatology : EJD|April 1, 2014
Hereditary apolipoprotein A1 amyloidosis with cutaneous and cardiac involvement: a long familial historyLuca Muscardin, Carlo Cota, Pietro Donati, et al.
Blood|September 16, 2011
Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissueFrancesca Brambilla, Francesca Lavatelli, Dario Di Silvestre, et al.
Journal of the Peripheral Nervous System : JPNS|June 23, 2011
Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patientsManuel Cappellari, Tiziana Cavallaro, Moreno Ferrarini, et al.
Journal of Cardiovascular Translational Research|October 9, 2013
Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosisGiampaolo Merlini, Violaine Planté-Bordeneuve, Daniel P Judge, et al.
Expert Review of Clinical Pharmacology|July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosisMorie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.
Haematologica|December 6, 2006
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosisVittorio Perfetti, Salvatore Siena, Giovanni Palladini, et al.
Annals of the Rheumatic Diseases|June 9, 2016
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II studyMarco Gattorno, Laura Obici, Marco Cattalini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2020
Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathyLuis F Maia, Aleksandra Maceski, Isabel Conceição, et al.
Arthritis and Rheumatism|October 1, 2004
First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndromeLaura Obici, Carlo Manno, Andrea Onetti Muda, et al.
Pageof 21